Medline, Inc. Non-Acute care — Net Sales increased by 6.8% to $1.73B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 6.8%, from $1.62B to $1.73B. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests successful penetration into the outpatient market and growing demand for non-acute medical supplies, while a decrease may indicate increased competition or reduced utilization in these care settings.
This metric represents the total revenue generated from the sale of medical-surgical products and supply chain solutions...
Peers in the medical distribution and manufacturing space typically report this as 'Outpatient' or 'Non-Acute' revenue, which is often compared against total segment growth rates to assess market share capture.
mdln_segment_non_acute_care_net_sales| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.47B | $1.47B | $1.47B | $1.47B | $1.56B | $1.56B | $1.56B | $1.56B | $1.62B | $1.73B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +6.1% | +0.0% | +0.0% | +0.0% | +3.7% | +6.8% |
| YoY Change | — | — | — | — | +6.1% | +6.1% | +6.1% | +6.1% | +3.7% | +6.8% |